SpinTEchPortfolio

SpinTechMRI and Cultivate news and press release

SpinTech MRI and Canon Medical Systems USA Breaking New Ground with the Development of a Fully Quantitative Fast MRI Solution for Clinical Use

Physics-based STAGE™ quantitative output and ground truth data used with Canon AiCE (Advanced intelligent Clear-IQ Engine) deep learning reconstruction could significantly expand MRI access for neuroimaging BINGHAM FARMS, MI, and TUSTIN, CA, Jan. 16, 2024 – SpinTech MRI, creators of the STAGE™ (STrategically Acquired Gradient Echo) quantitative magnetic resonance imaging (MRI) software platform, and Canon Medical Systems […]

SpinTech MRI and Canon Medical Systems USA Breaking New Ground with the Development of a Fully Quantitative Fast MRI Solution for Clinical Use Read More »

SpinTechMRI and Cultivate news and press release

SpinTech MRI and Yale New Haven Hospital to Examine Impact of STAGE on MRI

Collaboration will assess operational and clinical impacts of STAGE through an analysis of neuroimaging efficiency, reporting workflows and clinical outcomes in actual cases. BINGHAM FARMS, MI, Nov. 27, 2023 – SpinTech MRI, creators of the STAGE™ (Strategically Acquired Gradient Echo) quantitative magnetic resonance imaging (MRI) software platform, today announced that Yale New Haven Hospital and

SpinTech MRI and Yale New Haven Hospital to Examine Impact of STAGE on MRI Read More »

SpinTechMRI and Cultivate news and press release

culivate(MD) Capital Funds Announces Lead Participation in Portfolio Company SpinTech MRI’s Series A Financing

Grand Rapids, MI, July 25th, 2022 — Genesis Innovation Group’s cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Bingham Farms, MI based SpinTech MRI announced a $6.5 million Series A financing.

culivate(MD) Capital Funds Announces Lead Participation in Portfolio Company SpinTech MRI’s Series A Financing Read More »

SpinTechMRI and Cultivate news and press release

SpinTech Receives FDA 510(K) Clearance for STAGE™ Technology

HOLLAND, Mich., August 9th, 2021—Genesis Innovation Group’s cultivate(MD) Capital Fund II LP, a fund focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, SpinTech, has received FDA 510(k) clearance for their STAGE™ magnetic resonance imaging software. SpinTech is a privately-held medical device company at the frontier

SpinTech Receives FDA 510(K) Clearance for STAGE™ Technology Read More »